Date published: 2026-4-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

CYP4A Inhibitors

CYP4A inhibitors represent a significant class of chemical compounds that play a crucial role in modulating a specific group of enzymes known as cytochrome P450 4A enzymes. Cytochrome P450 enzymes are pivotal in the metabolism of various endogenous and exogenous substances, including drugs, environmental toxins, and fatty acids. Within the cytochrome P450 superfamily, the CYP4A subfamily stands out due to its paramount involvement in the oxidation of long-chain fatty acids, particularly those possessing terminal methyl or ethyl groups. CYP4A inhibitors are designed to selectively interfere with the enzymatic activity of CYP4A isoforms, thus exerting an influence over the metabolic pathways governed by these enzymes. The inhibitors achieve this by binding to the active site of the CYP4A enzymes, thereby preventing the usual substrate-enzyme interactions necessary for catalysis. As a result, the inhibitors contribute to the downregulation of the enzymatic hydroxylation and epoxidation reactions that are integral to the metabolism of certain fatty acids. The chemical structures of CYP4A inhibitors exhibit diverse arrangements, but they typically feature key functional groups or motifs that facilitate interaction with the enzyme's active site. These inhibitors can vary in terms of their specificity, potency, and mode of action. Inhibiting CYP4A enzymes can have cascading effects on various physiological processes, as these enzymes are implicated in the regulation of lipid homeostasis, inflammation, and cellular signaling. By modulating the activity of CYP4A enzymes, these inhibitors contribute to alterations in the production of lipid mediators and bioactive lipids, thereby influencing cellular responses to various external stimuli. Research into CYP4A inhibitors is ongoing, exploring the diverse implications of targeting these enzymes in different contexts. These inhibitors serve as indispensable tools in deciphering the intricate roles played by CYP4A enzymes in biochemical pathways. The development and refinement of CYP4A inhibitors contribute to a deeper understanding of lipid metabolism and related biological phenomena, paving the way for applications in diverse fields.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

HET-0016

339068-25-6sc-200673B
sc-200673
sc-200673D
sc-200673A
sc-200673C
1 mg
5 mg
10 mg
25 mg
100 mg
$24.00
$101.00
$150.00
$396.00
$1124.00
5
(1)

HET0016 is a selective inhibitor of CYP4A enzymes. It has been investigated for its role in reducing blood pressure and attenuating the development of hypertension.

1-Aminobenzotriazole

1614-12-6sc-200600
sc-200600A
50 mg
100 mg
$61.00
$134.00
6
(0)

ABT (1-aminobenzotriazole) is a general inhibitor of several cytochrome P450 enzymes, including CYP4A. It is often used in research to assess the involvement of CYP4A in various metabolic pathways.

Proadifen hydrochloride

62-68-0sc-200492
sc-200492A
250 mg
1 g
$144.00
$421.00
1
(1)

SKF-525A is another broad-spectrum cytochrome P450 inhibitor that can inhibit CYP4A enzymes. It has been used in studies to investigate the role of CYP4A in the metabolism of various drugs and xenobiotics.

Ciprofibrate

52214-84-3sc-204689
sc-204689A
25 mg
100 mg
$58.00
$172.00
(0)

Ciprofibrate is a fibrate drug used for dyslipidemia. It inhibits CYP4A enzymes, leading to alterations in lipid metabolism and triglyceride levels.

Gemfibrozil

25812-30-0sc-204764
sc-204764A
5 g
25 g
$66.00
$267.00
2
(2)

Gemfibrozil is another fibrate agent in research that inhibits CYP4A enzymes. Like ciprofibrate, it is used to manage dyslipidemia and lower triglyceride levels.